A cost-effectiveness analysis of four management strategies in the determination and follow-up of atypical squamous cells of undetermined significance
โ Scribed by Alice A. Hughes; Judith Glazner; Phoebe Barton; Judith C. Shlay
- Book ID
- 111660053
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 95 KB
- Volume
- 32
- Category
- Article
- ISSN
- 8755-1039
- DOI
- 10.1002/dc.20210
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The Bethesda System recommends that the diagnosis of "atypical squamous cells of undetermined significance" (ASCUS) be qualified when possible to indicate whether a reactive process, or a squamous intraepithelial lesion (SIL), is favored. In order to evaluate the utility of this recommendation, 308
The diagnosis of ASCUS (atypical squamous cells of undetermined significance) was introduced in the 1988 Bethesda System for reporting cervical/vaginal cytologic findings. Outcome and appropriate management of patients with this diagnosis is not presently established. Criteria defining ASCUS are nuc
## Background: The optimal management of low grade papanicolaou (pap) smear abnormalities remains controversial. this center's experience with recommending cytologic follow-up for women with atypical cells of undetermined significance (ascus) or low grade squamous intraepithelial lesions (lsil) was